When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 14 Mar 2025
Last updated: 13 Mar 2024

Summary

Definition

History and exam

Key diagnostic factors

  • fatigue
  • dry eyes
  • dry mouth

Other diagnostic factors

  • vasculitis
  • dental caries
  • presence of risk factors
  • increased oral fungal and bacterial infections
  • musculoskeletal pain
  • thyroid disease
  • urogenital disease
  • pulmonary disease
  • gastrointestinal disease
  • peripheral neuropathy
  • corneal ulceration
  • no saliva pool
  • enlarged salivary glands
  • facial pain
  • burning mouth syndrome

Risk factors

  • female
  • systemic lupus erythematosus (SLE)
  • rheumatoid arthritis
  • systemic sclerosis (scleroderma)
  • HLA class II markers
  • age 40 to 70
  • genetic inheritance

Diagnostic investigations

1st investigations to order

  • Schirmer's test
  • anti-60 kD (SS-A) Ro and anti-La (SS-B)

Investigations to consider

  • sialometry
  • minor salivary gland biopsy
  • lissamine green test
  • fluorescein corneal staining test
  • parotid sialography
  • salivary gland technetium-99m pertechnetate scintigraphy
  • skin biopsy
  • angiography
  • urinalysis
  • serum electrolytes

Emerging tests

  • MRI salivary glands
  • ultrasound salivary glands

Treatment algorithm

Contributors

Authors

Biji T. Kurien, PhD

Staff Scientist

Arthritis and Clinical Immunology Research Program

Oklahoma Medical Research Foundation

Research Associate

Department of Veterans Affairs

Oklahoma City

OK

Disclosures

BTK is an author of several articles cited in this topic.

R. Hal Scofield, MD

Professor

Section of Endocrinology and Diabetes

Department of Medicine

University of Oklahoma Health Sciences Center

Member

Arthritis and Clinical Immunology Research Program

Oklahoma Medical Research Foundation

Associate Chief of Staff for Research and Staff Physician

Department of Veterans Affairs Medical Center

Oklahoma City

OK

Disclosures

RHS has received compensation from Jessen Pharmaceuticals as a member of a clinical trial advisory board, and honorarium from Merck and Company for consultation on an investigational agent for Sjogren syndrome. RHS is the principal investigator for grants from the US National Institute of Health and the US Department of Veteran Affairs for institutions studying Sjorgren syndrome. RHS is an author of several articles cited in this topic.

Peer reviewers

Nora Sandorfi, MD

Associate Professor of Medicine

University of Pennsylvania

Philadelphia

PA

Disclosures

NS declares she has no competing interests.

Use of this content is subject to our disclaimer